🇰🇷 Halflytely in South Korea

Halflytely (BISACODYL) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Halflytely in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in South Korea

Frequently asked questions

Is Halflytely approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Halflytely in South Korea?

Braintree is the originator. The local marketing authorisation holder may differ — check the official source linked above.